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Background: It was recently shown that niacin supplementation counteracts the obesity-induced muscle fiber
transition from oxidative type I to glycolytic type II and increases the number of type I fibers in skeletal muscle of
obese Zucker rats. These effects were likely mediated by the induction of key regulators of fiber transition, PPARδ
(encoded by PPARD), PGC-1α (encoded by PPARGC1A) and PGC-1β (encoded by PPARGC1B), leading to type II to
type I fiber transition and upregulation of genes involved in oxidative metabolism. The aim of the present study
was to investigate whether niacin administration also influences fiber distribution and the metabolic phenotype of
different muscles [M. longissimus dorsi (LD), M. semimembranosus (SM), M. semitendinosus (ST)] in sheep as a model
for ruminants. For this purpose, 16 male, 11 wk old Rhoen sheep were randomly allocated to two groups of 8 sheep
each administered either no (control group) or 1 g niacin per day (niacin group) for 4 wk.
Results: After 4 wk, the percentage number of type I fibers in LD, SM and ST muscles was greater in the niacin
group, whereas the percentage number of type II fibers was less in niacin group than in the control group
(P < 0.05). The mRNA levels of PPARGC1A, PPARGC1B, and PPARD and the relative mRNA levels of genes involved in
mitochondrial fatty acid uptake (CPT1B, SLC25A20), tricarboxylic acid cycle (SDHA), mitochondrial respiratory chain
(COX5A, COX6A1), and angiogenesis (VEGFA) in LD, SM and ST muscles were greater (P < 0.05) or tended to be
greater (P < 0.15) in the niacin group than in the control group.
Conclusions: The study shows that niacin supplementation induces muscle fiber transition from type II to type I, and
thereby an oxidative metabolic phenotype of skeletal muscle in sheep as a model for ruminants. The enhanced capacity
of skeletal muscle to utilize fatty acids in ruminants might be particularly useful during metabolic states in which fatty
acids are excessively mobilized from adipose tissue, such as during the early lactating period in high producing cows.
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Pharmacological doses of niacin have long been known
to lower the levels of blood lipids, especially triacylglyc-
erols (TAG), but the mechanism underlying this effect is
only incompletely understood. Even though it has been
established that niacin inhibits lipolysis in adipocytes
through binding to the niacin-receptor HCA2 and there-
by reduces the supply of non-esterified fatty acids (NEFA)
for hepatic TAG synthesis [1], this effect can only insuffi-
ciently explain the lipid-lowering effect because blood* Correspondence: klaus.eder@ernaehrung.uni-giessen.de
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reproduction in any medium, provided the orNEFA levels even become elevated during long-term nia-
cin treatment due to a strong rebound phenomenon on
lipolysis while the TAG lowering effect remains [2]. How-
ever, less well-documented niacin treatment also causes
significant changes in gene expression in other tissues
than adipose tissue, like skeletal muscle [2], a tissue which
due to its great mass is particularly important for whole
body fatty acid utilization. Noteworthy, it has been
recently shown in humans that niacin administration in-
duces the expression of two transcription factors, peroxi-
some proliferator-activated receptor δ (PPARδ, encoded
by PPARD) and PPARγ coactivator-1α (PGC-1α, encoded
by PPARGC1A) in skeletal muscle [3]. Both transcription
factors are key regulators of muscle fiber composition and
the muscle’s metabolic phenotype because they controld. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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utilization, oxidative phosphorylation, mitochondrial bio-
genesis and function [4,5], and angiogenesis [6]. Skeletal
muscle contains two major types of muscle fibers which
differ in their contractile proteins and their metabolic cap-
acity [7]. The type II fibers (“glycolytic fibers”) have a little
number of mitochondria and largely generate ATP
through glycolytic metabolism, whereas type I fibers (“oxi-
dative fibers”) are mitochondria-rich and thus utilize
mainly oxidative phosphorylation [8,9]. Interestingly, the
distribution of type I and type II fibers of skeletal muscles
shows high plasticity and can be altered by diverse factors,
such as exercise, mechanical unloading, obesity or dia-
betes, resulting in a change of the muscle’s functional and
metabolic phenotype [10-13]. In an attempt to study
whether the induction of PPARδ and PGC-1α in skeletal
muscle by pharmacological niacin doses leads to a change
of muscle fiber distribution and the muscle’s metabolic
phenotype, we have previously tested the effect of niacin
supplementation at a dose used for reduction of serum
lipids in obese Zucker rats [14] and pigs [15]. Both studies
revealed that niacin supplementation induces muscle fiber
transition from type II to type I and increases the number
of type I fibers in skeletal muscle [14,15]. Moreover, we
found that the expression of genes involved in fatty acid
transport, mitochondrial fatty acid import and oxidation,
oxidative phosphorylation and angiogenesis and genes
encoding PPARδ, PGC-1α and PGC-1β (encoded by
PPARGC1B), which, like PGC-1α, is a key regulator of
skeletal muscle’s oxidative and contractile phenotype [16],
in skeletal muscle is elevated by niacin treatment [14,15].
Thus, these findings suggest that niacin induces a change
in the muscle metabolic phenotype which is indicative of
an increased capacity of muscle for oxidative utilization of
fatty acids and which might be useful during metabolic
states where TAG and NEFA are strongly elevated, such
as during early lactation in high producing dairy cows
[17]. However, whether niacin treatment also causes type
II to type I muscle fiber switching and increases the type I
fiber content of skeletal muscles in ruminants has not
been investigated yet. Thus, the present study aimed to
investigate whether niacin administration at a pharma-
cological dose influences fiber distribution and the meta-
bolic phenotype of different skeletal muscles in sheep as
a model for ruminants. Niacin was administrated by
drenching ensuring that the main part of the adminis-
trated niacin bypasses the rumen and reaches the small
intestine.
Methods
Animals, housing, and experimental design
The experiment was located at the Research Station of
the Institute of Animal Breeding and Genetics at the
University of Giessen, Germany. A total of 16 male, 11wk old Rhoen sheep with an average body weight of
29.6 ± 3.0 (mean ± SD) kg were randomly allocated to
two groups of 8 sheep each (control group and niacin
group). All sheep within one group were kept together
in a barn on straw. All sheep received hay ad libitum
and 1.5 kg concentrate per day and sheep. The hay con-
tained (% of dry matter) 47.5% nitrogen-free extractable
substances, 30.3% crude fiber, 7.0% crude protein, 6.1%
crude ash and 1.1% crude fat. The concentrate (RWZ-
Schaf 18 Uni Press, RWZ, Köln) consisted of (g/kg):
Root pulp (250), wheat (200), dried distillers grains with
solubles (120), wheat bran (104), wheat gluten feed
(100), rapeseed extraction meal (100), soybean extraction
meal (37), calcium carbonate (22), soy hulls (20), molasses
(20), vinasse (10), monocalcium phosphate (8), sodium
chloride (1.9), magnesium oxide (1.6) and a premix sup-
plying vitamins and minerals (5.5; amounts of vitamins
and minerals supplied per kg: vitamin A, 8,000 IE; vitamin
D3, 1,000 IE; vitamin E, 65 mg; zinc, 40 mg as zinc sulfate
monohydrate; manganese, 20 mg as manganese (II) sulfate
monohydrate; selenium, 0.2 mg as sodium selenite; cobalt,
0.2 mg as cobalt (II) sulfate monohydrate; iodine, 0.1 mg
as calcium iodate). According to the manufacturer’s
declaration the concentrate contained 10.6 MJ ME/kg
and 18% crude protein. Additionally, sheep of the niacin
group received 1 g niacin (obtained from Lonza, Basel,
Switzerland) dissolved in 100 ml drinking water by
drenching daily at eleven a.m. Sheep of the control
group were given the same amount of drinking water by
drenching without addition of niacin. Since the concen-
trate did not contain any supplemental niacin, the sheep
of the control group received only the niacin contained
in the hay and the feed components of the concentrate,
from which no actual concentrations of niacin are avail-
able. Based on literature data, the niacin concentration
in hay and concentrate is below 100 mg/kg dry matter
[18]. The experimental period during which sheep were
administered either no (control group) or 1 g niacin per
day (niacin group) lasted for 4 wk. Water was given ad
libitum. All experimental procedures were in strict ac-
cordance with the recommendations in the guidelines
for the care and use of laboratory animals [19] and the
Appendix A of European Convention for the Protection
of Vertebrate Animals used for Experimental and other
Scientific Purposes. In accordance with article 4 par. 3
of the German Animal Welfare Law all animals were
humanely killed for scientific purpose approved by the
Animal Welfare Officer of the Justus-Liebig-University.
Sample collection
After 4 wk the animals were slaughtered at a commercial
slaughterhouse located in the near of the Research Sta-
tion. Blood samples were taken into EDTA polyethylene
tubes (Sarstedt, Nürnbrecht, Germany) and plasma was
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Samples from three different skeletal muscles [M. longissi-
mus dorsi (LD), M. semimembranosus (SM), M. semitendi-
nosus (ST)] were excised nearly at the same location and
samples were shock frozen with liquid nitrogen and stored
at −80°C pending analysis.
Muscle fiber typing
Fiber typing was performed as recently described in de-
tail [14]. In brief, 30 μm thick, serial cross sections were
taken using a cryostat microtome, mounted on cover
slips and stained for myosin ATPase (mATPase) using a
modified method of Hämäläinen and Pette [20]. In brief,
sections were pre-incubated for 5 min in sodium acetate
(54.3 mM) – sodium barbital (32.6 mM) solution ad-
justed with hydrogen chloride to pH 4.6. After washing,
the sections were incubated for 30 min at 37°C in sub-
strate solution (2.7 mM ATP, 100 mM glycin, 54 mM
calcium (II) chloride, 100 mM sodium chloride, pH ad-
justed to 9.6). Following incubation in 1% calcium (II)
chloride and 2% cobalt (II) chloride, a black insoluble
compound was developed in 1% ammonium sulfide for
50 s leading to a black staining of type I fibers and grey
staining of type II fibers. Subsequently, the sections were
analyzed by light microscopy (Leica DMI 6000B) for cal-
culating the type I and type II fiber percentages. Fiber
typing was carried out in the best five images out of ten
stained sections per muscle and animal, and all fibers
within a 100 cm2 area were calculated. This area corre-
sponded to about 60 fibers. Thus, a total of 300 fibers
were calculated per animal and muscle.
Determination of nicotinic acid and nicotinamide
concentrations in plasma
Concentrations of nicotinic acid and nicotineamide in
plasma were determined by LC-MS/MS according to the
method from Liu et al. [21].
Determination of plasma lipids
The plasma concentrations of TAG and NEFA were
measured using enzymatic reagent kits from Merck
Eurolab (ref. 113009990314) and from Wako Chemicals
(ref. RD291001200R), respectively.
RNA isolation and qPCR analysis
RNA isolation, cDNA synthesis qPCR analysis were per-
formed as described recently in detail [22]. In brief, total
RNA was isolated from 25–30 mg skeletal muscle aliquots
using Trizol™ reagent (Invitrogen, Karlsruhe, Germany),
and RNA concentration and purity were estimated from
the optical density at 260 and 280 nm (Infinite 200 M
microplate reader, Tecan, Männedorf, Switzerland).
RNA integrity was assessed by confirming intact bands
corresponding to the 18S and 28S ribosomal RNAsubunits using 1% agarose gel electrophoresis. Following
cDNA synthesis within one week after RNA isolation
using dT18 primer and M-MuLV Reverse Transcriptase
(MBI Fermentas, St. Leon-Rot, Germany), qPCR ana-
lysis was performed as described recently in detail [22].
Features of gene-specific primer pairs are listed in Table 1.
Calculation of gene expression data and normalization by
GeNorm normalization factor were carried out as de-
scribed recently [22]. The normalization factor was calcu-
lated as the geometric mean of expression data of the
three most stable out of six tested potential reference
genes (RPL19, YWHAZ, RPS26, MDH1, B2M, and
GAPDH). In each muscle the three most stable reference
genes were the same (the stability score M as calculated
by GeNorm is shown in brackets): LD muscle: RPL19
(0.025), YWHAZ (0.026), and RPS26 (0.029); SM muscle:
RPL19 (0.026), YWHAZ (0.028), and RPS26 (0.028); ST
muscle: RPL19 (0.033), YWHAZ (0.037), and RPS26
(0.040). Means and SD were calculated from normalized
expression data for samples of the same treatment group.
The mean of the group control was set to 1 and mean and
SD of the niacin group were scaled proportionally. Data
on qPCR performance for target and reference genes mea-
sured in skeletal muscle are shown in Table 2.
Immunoblotting
Preparation of homogenates, determination of protein
concentration and immunoblotting were performed as
described recently in detail [23]. In brief, proteins were
separated by 12,5% SDS-PAGE, transferred to a nitrocel-
lulose membrane and incubated with primary antibodies
against PGC-1α (dilution 1:1000; polyclonal anti-PGC-1α
antibody; Millipore, Temecula, CA), PPARδ (dilution 1:1000;
polyclonal anti-PGC-1α antibody; Abcam, Cambridge, UK),
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(dilution 1:5000; monoclonal anti-GAPDH antibody, Abcam,
Cambridge, UK) as a reference protein. Nitrocellulose mem-
branes were washed, and subsequently incubated with a
horseradish peroxidase conjugated secondary monoclonal
anti-mouse-IgG antibody (Abcam, Cambridge, UK) for
GAPDH and polyclonal anti-rabbit-IgG antibody (Sigma-
Aldrich, St. Louis, Germany) for PGC-1α, and PPARδ at
room temperature. Finally, blots were developed by either
ECL Select or ECL Prime (both GE Healthcare, Munich,
Germany), respectively, and the intensities of the specific
bands detected with a Bio-Imaging system (Syngene,
Cambridge, UK) and quantified by Syngene GeneTools
software (nonlinear dynamics).
Statistics
Data were statistically analysed by Student’s t-test using
the Minitab Statistical Software (Rel. 13.0, State College,
PA, USA). Means were considered significantly different
for P < 0.05. Data presented are shown as means ± SD.
Table 2 qPCR performance data
Gene Slope R2# Efficiency*
B2M −3.20 0.999 2.05
COX5A −3.22 0.999 2.04
COX6A1 −2.99 0.997 2.16
CPT1B −3.79 0.996 1.84
GAPDH −2.97 0.999 2.17
MDH1 −3.21 0.999 2.05
MHCI −3.37 1.000 1.98
MHCIIA −3.21 0.998 2.05
MHCIIX −3.29 0.999 2.01
PPARD −3.05 0.967 2.13
PPARGC1A −3.34 0.999 1.99
PPARGC1B −3.29 0.956 2.01
RPL19 −3.31 0.997 2.00
RPS26 −3.72 0.998 1.86
SDHA −3.12 0.999 2.09
SLC25A20 −3.81 0.980 1.83
VEGFA −3.31 0.997 2.00
YWHAZ −3.34 0.993 1.99
#Coefficient of determination of the standard curve.
*The efficiency is determined by [10(−1/-slope].
Table 1 Characteristics of primers used for qPCR
Gene Forward primer (3′-5′) Reverse primer (5′-3′) Product length (bp) Tm (°C) NCBI Genbank
Reference genes
B2M GCGTATTCCAGAGGTCCAGG CGGCAGCTGTACTGATCCTT 234 60 NM_001009284
GAPDH GGCGTGAACCACGAGAAGTA GCAGGGATGATGTTTTGGGC 227 60 AF022183
MDH1 TACGTGTTCCCTGGAGTTGC TGCTTCCTTGTTTGGGGGTT 249 57 NM_001135220
RPL19 AGCCTGTGACTGTCCATTCC TTCTCGGGCATTCGAGCATT 118 57 JN811679
RPS26 ACAACGGTCGTGCCAAAAAG AAATCGGGGTGGAGGTGTTC 284 57 NM_001009435
YWHAZ AGACGGAAGGTGCTGAGAAA TGGGGATCAAGAACTTTTCCAA 120 57 JN811681
Target genes
COX5A GCTCGCTGGGTGACATACTT ACCTCTAGGATGCGAACTGC 173 60 AF233074
COX6A1 TGCAGCTGAGTCGGTGTATG GAACTCGGGTCTCTCCTCCT 161 60 GU585577
CPT1B GACGTTTCCATGGGACTGGT GCCAGCGTCTCCATTCGATA 389 60 NM_001009259
MHCI TCGTCAAGGCCACAATTTTG CTGTCGCAACACCTGGTCCT 100 60 AB058898
MHCIIA AAGCCTTTTGATGCCAAGACAT TTCACCGTCACTTTCCCACC 100 60 AB058896
MHCIIX CTTCGTGGCGGACCCTAAG CAGTTACTGTCGCCCCAGCT 100 60 AB058897
PPARD TCAGCGTGCACGTCTTCTAC CAGGAATTCCCGGGTGACAA 230 59 XM_004018769
PPARGC1A GGTGACCATGACTATTGTCAG CTCGGATTTCCTGGTCTTGAA 216 58 XM_004009738
PPARGC1B CTGGACCGAGTTCTCCATCC CACGTGCCCTTTCACCTGCA 244 61 XM_004008965
SDHA GTTTGAGCAGCACTGGAGGA AGTCGGTCTCGTTCAAAGTCC 110 60 DQ386895
SLC25A20 CCGAGGGATCTACAAGGGGA CCTTCATCCCGGATCAGCTC 288 61 NM_001127277
VEGFA GGACATCTTCCAGGAGTACC GCATGGTGATGTTGAACTCCT 137 58 EU857623
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Final body weight, body weight gain and carcass weight
Final body weights, daily body weight gain and carcass
weights did not differ between the control group and the
niacin group (Final body weight: 37.4 ± 2.3 vs. 37.8 ± 3.7 kg;
daily body weight gain: 308 ± 50 vs. 308 ± 41 g; carcass
weight: 17.2 ± 1.4 vs. 17.3 ± 2.4 kg; control group vs. niacin
group; n = 8/group).
Concentrations of nicotinic acid and its metabolite
nicotinamide in plasma
The plasma concentrations of nicotinic acid and its me-
tabolite nicotinamide were greater in the niacin group
than in the control group (nicotinic acid: 0.41 ± 0.31 vs.
0.75 ± 0.42 μg/mL; nicotinamide: 0.46 ± 0.25 vs. 3.42 ±
0.90 μg/mL; control group vs. niacin group; P < 0.05).
Lipid concentrations in plasma
In order to assess the lipid-lowering properties of niacin
in sheep, we determined the plasma concentrations of
NEFA and TAG. The plasma TAG concentration tended
to be lower in the niacin group than in the control
group (0.20 ± 0.02 vs. 0.17 ± 0.03 mmol/L; control group
vs. niacin group; P < 0.1). The plasma NEFA concentra-
tion did not differ between the niacin and the control
group (0.32 ± 0.11 vs. 0.29 ± 0.14 mmol/L; control group
vs. niacin group).
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fiber-specific myosin heavy chain (MHC) isoforms
in skeletal muscles
To evaluate an effect of niacin on fiber type distribution,
muscle fiber typing and transcript level measurement of
fiber-specific MHC isoforms was carried out. As shown
in Figure 1A, the percentage number of type I fibers in
LD muscle, SM muscle and ST muscle was greater in
the niacin group than in the control group, whereas the
percentage number of type II fibers was less in niacin
group than in the control group (P < 0.05). The PCR
primers used to detect transcript levels of sheep MHC
isoforms corresponding to MHCI, MHCIIA and MHCIIX
have been designed based on available sheep partial-Control Niacin
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Figure 1 Muscle fiber type distribution (A), and relative mRNA levels
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“black” areas being the type I fibers and the “grey” ones being the type II f
group, P < 0.15.length cDNA sequences [24]. Specific PCR primers for
sheep MHCIIB transcripts could not be designed because
no sheep MHCIIB cDNA sequence is available in nucleic
acid databases. As shown in Figure 1B, the mRNA level of
type I-specific MHCI in SM muscle and ST muscle was
increased in the niacin group compared to the control
group (P < 0.05). In LD muscle, the mRNA level of MHCI
was numerically greater in the niacin group relative to the
control group (P = 0.24). The mRNA level of MHCIIA
was decreased in LD muscle and SM muscle of the niacin
group compared to the control group (P < 0.05), but did
not differ between groups in ST muscle. The mRNA level
of MHCIIX in LD muscle and SM muscle was signifi-
cantly less (P < 0.05) and tended to be less (P < 0.15),*
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In ST muscle, the mRNA level of MHCIIX was not differ-
ent between groups.
Expression of key regulators of muscle fiber transition in
skeletal muscles
To explore the mechanisms underlying the niacin-
induced muscle fiber transition we determined mRNA
and/or protein levels of the key regulators of muscle
fiber transition, PGC-1α, PGC-1β and PPARδ, in the
three muscles. The mRNA level of PPARGC1A in all three
muscles was greater in the niacin group than in the control
group (P < 0.05; Figure 2). The mRNA level of PPARGC1B
was greater in LD muscle (P < 0.05) and tended to be
greater in SM muscle and ST muscle (P < 0.15) of the nia-
cin group than in the control group (Figure 2). The mRNA
level of PPARD was increased in LD muscle and ST
muscle (P < 0.05) and tended to be increased in SM muscle
(P < 0.15; Figure 2). The protein level of PGC-1α was ele-
vated in LD muscle and SM muscle of the niacin group
compared to the control group (P < 0.05), but did not differ
in ST muscle between groups (Figure 2). The protein level
of PPARδ in all three muscles did not differ between
groups.
Expression of genes involved in fatty acid oxidation,
mitochondrial respiratory chain and angiogenesis in
skeletal muscles
Since PGC-1α and PPARδ are important regulators of
genes involved in fatty acid oxidation, mitochondrial re-
spiratory chain and angiogenesis, we determined mRNA
levels of CPT1B and SLC25A20, which encode two en-
zymes of the carnitine shuttle system, SDHA, which
encodes the tricarboxylic acid cycle (TCA) enzyme suc-
cinate dehydrogenase, COX6A1 and COX5A, which en-
code two subunits of the respiratory chain complex IV
(cytochrome c oxidase), and VEGFA encoding the angio-
genic factor VEGF-a. Relative mRNA levels of COX5A,
COX6A1, VEGFA, CPT1B, and SLC25A20 in all three
muscles were greater in the niacin group than in the
control group (P < 0.05; Figure 3). In addition, the rela-
tive mRNA level of SDHA in SM muscle and ST muscle
was greater in the niacin group than in the control
group (P < 0.05; Figure 3). In LD muscle, the mRNA
level of SDHA tended to be greater in the niacin group
than in the control group (P < 0.15; Figure 3).
Discussion
In the present study we tested the hypothesis that, like
in rats and pigs [14,15], niacin supplementation induces
muscle fiber transition from type II (glycolytic) to type I
(oxidative), and thereby an oxidative metabolic pheno-
type of skeletal muscle in sheep as a ruminant model.
The dietary niacin dosage (1 g niacin per day) given tothe sheep related to 27–35 mg/kg body weight which is
only slightly below that given to the rats (40–54 mg/kg
body weight [14]) and pigs (30–49 mg/kg body weight
[15]) in our recent studies and which was shown to
induce a muscle fiber switch from type II to type I in
skeletal muscle. The niacin dosage administered by
drenching to the sheep of the niacin group was markedly
higher than that taken up from the feed ration (hay and
concentrate) by the sheep of the control group, because
according to literature data the native concentration of
niacin in hay and the main components of the concen-
trate is below 100 mg/kg dry matter [18]. In line with
this, the niacin administration to the sheep caused a sig-
nificant increase in the plasma concentration of the nic-
otinic acid metabolite nicotinamide. In addition, it has
to be considered that the sheep used in this study had
already fully developed rumen. This means that the nia-
cin requirement for the sheep was covered from niacin
synthesized by the rumen microbes and that the niacin
from the ingested hay and concentrate was largely de-
graded by rumen microbes [25]. In contrast, the drench-
ing procedure, which was used to administer the daily
niacin bolus, is a suitable approach to ensure that the
main part of the administered niacin bypasses the rumen
and reaches the small intestine. In the present study, we
considered three different skeletal muscles, LD, SM and
ST, containing predominantly type II fibers (the type II
fiber percentage in all three muscles in the control group
was approximately 81%), because we expected an effect
of niacin only in skeletal muscles with a high percentage
of type II fibers. The main finding of the present study is
that supplementation of niacin induces muscle fiber
switching also in skeletal muscles of sheep. Muscle fiber
typing revealed that the type I fiber percentage in the
three muscles investigated increased from approximately
18–20% in the control group to 30–31% in the niacin
group, whereas the type II fiber percentage decreased
from 81% to 69%. In line with this, we observed that the
mRNA level of the type I-specific MHCI was signifi-
cantly greater in SM muscle and ST muscle and tended
to be greater in LD muscle, but the mRNA levels of type
II-specific MHC isoforms in LD and SM muscle were
less in the niacin group than in the control group.
Regarding that muscle fiber transition is induced on
the molecular level by an increased activity of PGC-1α,
PGC-1β and PPARδ [4,5,26,27], we determined the
mRNA and/or protein levels of these key regulators in
the three muscles. We found that the mRNA level of
PPARGGC1A in all three muscles was markedly ele-
vated, and the mRNA levels of PPARGC1B and PPARD
in all three muscles were either significantly increased or
tended to be increased in the niacin group compared to
the control group. In addition, the protein level of PGC-
1α in two of three muscles was greater in the niacin than
**
*
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
PPARGC1A PPARGC1B PPARD
*
#
#
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
PPARGC1A PPARGC1B PPARD
*
#
*
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
PPARGC1A PPARGC1B PPARD
R
el
at
iv
e 
m
RN
A 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
R
el
at
iv
e 
m
RN
A 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
R
el
at
iv
e 
m
RN
A 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
R
el
at
iv
e 
pr
ot
ei
n 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
R
el
at
iv
e 
pr
ot
ei
n 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
R
el
at
iv
e 
pr
ot
ei
n 
le
ve
l
(fo
ld 
of
 co
nt
ro
l) 
Niacin
Control
Niacin
Control
Niacin
Control
LD muscle
SM muscle
ST muscle
A B
PGC-1α
PPARδ
GAPDH
Control Niacin
*
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
PGC-1α PPARδ
*
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
PGC-1α PPARδ
PGC-1α
PPARδ
GAPDH
Control Niacin
PGC-1α
PPARδ
GAPDH
Control Niacin
Niacin
Control
Niacin
Control
Niacin
Control
0.00
0.50
1.00
1.50
2.00
PGC-1α PPARδ
LD muscle
SM muscle
ST muscle
Figure 2 (See legend on next page.)
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Figure 2 Relative mRNA levels of PPARGC1A, PPARGC1B and PPARD (A), and relative protein levels of PGC-1α and PPARδ (B) in LD
muscle, SM muscle, and ST muscle of sheep administered either no (control group) or 1 g niacin per day (niacin group) for 4 wk. Bars
represent means ± SD, n = 8 (mRNA) and 6 (protein) sheep/group. Representative immunoblots specific to PGC-1α, PPARδ and GAPDH as internal
control are shown for one animal per group; immunoblots for the other animals revealed similar results. *different from control group, P < 0.05,
#different from control group, P < 0.15.
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in all muscles was not different between groups. The
PGC-1β protein level could not be determined, because
no appropriate antibody to reliably detect PGC-1β was
available. We cannot definitely explain the lack of effectR
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sheep administered either no (control group) or 1 g niacin per day (nia
*different from control group, P < 0.05; #different from control group, P < 0.of niacin on PPARδ protein levels, but this may be due
to the comparatively small sensitivity of the western
blotting technique making it difficult to detect slight dif-
ferences between groups. However, the unaltered protein
level of PPARδ does not exclude that its DNA-bindingNiacin
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cin group) for 4 wk. Bars represent means ± SD for n = 8 sheep/group.
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http://www.actavetscand.com/content/55/1/85activity was increased because it is known that PGC-1α
and PGC-1β, whose genes expression was clearly in-
creased, act as coactivators of PPARδ and enhance the
transactivation activity of PPARδ [28]. Therefore, our
finding suggests that niacin supplementation increases
the transcriptional activity of these critical regulators of
muscle fiber transition, and thus provides an explanation
for the increased type I fiber content in skeletal muscles
of niacin-treated sheep.
Type I fibers, also called slow-twitch oxidative fibers,
contain a high number of mitochondria, have a high oxi-
dative capacity, and preferentially use fatty acids for en-
ergy production [8,9]. This oxidative metabolic phenotype
of type I fibers is the consequence of a markedly higher
expression of genes involved in fatty acid transport and
uptake, β-oxidation, carnitine shuttle, TCA cycle and re-
spiratory chain compared to glycolytic type II fibers
[26,27]. In addition, type I fibers exhibit a higher expres-
sion of angiogenic factors, like VEGFA, which favors the
preferential use of fatty acids by type I fibers because an-
giogenic factors increase capillary density and thereby
blood perfusion but also the expression of fatty acid trans-
port proteins [29]. In the present study we could demon-
strate that several genes encoding proteins involved in
oxidative metabolism (SDHA, COX5A, COX6A1, VEGFA,
CPT1B, SLC25A20) were up-regulated in the muscles of
the niacin group compared to the control group which is
in line with the niacin-induced changes in fiber type distri-
bution and expression of MHC isoforms. Although we did
not provide data showing that the increased expression of
oxidative genes is also accompanied by an enhanced activ-
ity of the encoded enzymes and an elevated capillary dens-
ity, we suggest that the niacin-induced changes in skeletal
muscle mRNA levels are indicative of an improved oxida-
tive capacity because it is well known that the changes in
the muscle’s metabolic and contractile phenotype are in-
duced at the transcriptional level through an enhanced ac-
tivity of PGC-1α and PPARδ [26,27].
Conclusions
The results of this study show that niacin supplementation
in sheep as a model for ruminants induces muscle fiber
transition from type II (glycolytic) to type I (oxidative)
being indicative of a change of the muscle’s metabolic
phenotype towards a more oxidative one. An enhanced
capacity of skeletal muscle to utilize fatty acids in rumi-
nants might be particularly useful during metabolic states
in which fatty acids are extensively mobilized from adi-
pose tissue, such as during the early lactating period in
high producing cows. In addition, considering that sev-
eral studies have reported that oxidative muscles with a
high percentage of type I fibers have a lower glycolytic
potential, a darker color and a higher ultimate pH
[30-32], the niacin-induced change in the muscle’s fibertype distribution may influence meat quality. At least in
pigs it was demonstrated that oxidative muscle types
tend to develop dark, firm and dry pork in response to
intense physical activity and/or high psychological stress
levels preslaughter [33]. Thus future studies have to in-
vestigate whether niacin administration influences meat
quality from sheep.
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